Aniko Szabo

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay
    Laurent Perreard
    The ARUP Institute for Clinical and Experimental Pathology, SLC, Utah, USA
    Breast Cancer Res 8:R23. 2006
  2. ncbi A conscious mouse model of gastric ileus using clinically relevant endpoints
    Matthew A Firpo
    Department of Surgery, University of Utah School of Medicine, 30 N 1900 E, Salt Lake City, UT 84132, USA
    BMC Gastroenterol 5:18. 2005
  3. ncbi Statistical modeling for selecting housekeeper genes
    Aniko Szabo
    Department of Oncological Sciences, Huntsman Cancer Institute, Salt Lake City, UT 84112, USA
    Genome Biol 5:R59. 2004
  4. ncbi Multivariate exploratory tools for microarray data analysis
    Aniko Szabo
    Huntsman Cancer Institute and Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Biostatistics 4:555-67. 2003
  5. ncbi Estimating an oncogenetic tree when false negatives and positives are present
    Aniko Szabo
    Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Math Biosci 176:219-36. 2002
  6. ncbi Variable selection and pattern recognition with gene expression data generated by the microarray technology
    A Szabo
    Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Math Biosci 176:71-98. 2002
  7. ncbi Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues
    Michael Mullins
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA
    Clin Chem 53:1273-9. 2007
  8. ncbi Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo
    David E Joyner
    SAR Lab, Sarcoma Services, Department of Orthopedics, Huntsman Cancer Institute and Primary Children's Medical Center, University of Utah, Salt Lake City, UT 84112, USA
    J Cancer Res Clin Oncol 131:137-46. 2005
  9. ncbi Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis
    Jonathan D Tward
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 107:2392-400. 2006
  10. ncbi The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
    Jonathan D Tward
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112 5560, USA
    Cancer 107:108-15. 2006

Research Grants

  1. Understanding racial differences in the natural history of prostate cancer
    Aniko Szabo; Fiscal Year: 2007

Detail Information

Publications20

  1. ncbi Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay
    Laurent Perreard
    The ARUP Institute for Clinical and Experimental Pathology, SLC, Utah, USA
    Breast Cancer Res 8:R23. 2006
    ..The proliferation meta-gene offers an objective and quantitative measurement for grade and adds significant prognostic information to the biological subtypes...
  2. ncbi A conscious mouse model of gastric ileus using clinically relevant endpoints
    Matthew A Firpo
    Department of Surgery, University of Utah School of Medicine, 30 N 1900 E, Salt Lake City, UT 84132, USA
    BMC Gastroenterol 5:18. 2005
    ....
  3. ncbi Statistical modeling for selecting housekeeper genes
    Aniko Szabo
    Department of Oncological Sciences, Huntsman Cancer Institute, Salt Lake City, UT 84112, USA
    Genome Biol 5:R59. 2004
    ..We present appropriate models for selecting the best housekeepers to normalize quantitative data within a given tissue type (for example, breast cancer) and across different types of tissue samples...
  4. ncbi Multivariate exploratory tools for microarray data analysis
    Aniko Szabo
    Huntsman Cancer Institute and Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Biostatistics 4:555-67. 2003
    ..Different stopping rules associated with this procedure are evaluated. The usefulness of the proposed approach is illustrated with an application to the analysis of two sets of gene expression data...
  5. ncbi Estimating an oncogenetic tree when false negatives and positives are present
    Aniko Szabo
    Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Math Biosci 176:219-36. 2002
    ..As an example we analyze a comparative genomic hybridization data set and show that addition of the error model significantly improves the ability of the model to describe the data...
  6. ncbi Variable selection and pattern recognition with gene expression data generated by the microarray technology
    A Szabo
    Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Math Biosci 176:71-98. 2002
    ....
  7. ncbi Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues
    Michael Mullins
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA
    Clin Chem 53:1273-9. 2007
    ....
  8. ncbi Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo
    David E Joyner
    SAR Lab, Sarcoma Services, Department of Orthopedics, Huntsman Cancer Institute and Primary Children's Medical Center, University of Utah, Salt Lake City, UT 84112, USA
    J Cancer Res Clin Oncol 131:137-46. 2005
    ..CONCLUSIONS: Linear discriminate analysis of cDNA gene expression profiles partitioned mesenchymal tumor classes, even when constrained by limited sample sizes...
  9. ncbi Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis
    Jonathan D Tward
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 107:2392-400. 2006
    ..The optimal treatment for men with early stage prostate cancer remains undefined. Survival of such patients after surgery, brachytherapy, or no definitive therapy was investigated specifically to determine the impact of age at diagnosis...
  10. ncbi The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
    Jonathan D Tward
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112 5560, USA
    Cancer 107:108-15. 2006
    ..Survivors of non-Hodgkin lymphoma (NHL) are at increased risk for developing secondary malignancies. For the current study, the authors quantitated this risk in a group of NHL survivors over 30 years of follow-up...
  11. ncbi Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index
    Margaret K Yu
    School of Medicine, Division of Hematology, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA
    Leuk Res 31:773-7. 2007
    ..Using Cox proportional hazard models for MI, adjusting for age and white blood cell count, only the DNA MI correlated with early clinical indications for systemic therapy (p=0.0038, HR=7.00, 95% CI: 1.90-26.20)...
  12. ncbi Adjustments and measures of differential expression for microarray data
    A Tsodikov
    Huntsman Cancer Institute and Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112 5550, USA
    Bioinformatics 18:251-60. 2002
    ..We found that robust categorical adjustments outperform the ones based on a precisely defined stochastic model, including some commonly used procedures...
  13. ncbi The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
    Aaron P Brown
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, 1950 Circle of Hope, Salt Lake City, Utah 84112 5560, USA
    J Clin Endocrinol Metab 93:504-15. 2008
    ..The 10-yr survival rate of patients with differentiated thyroid cancer exceeds 90%. These patients may be at elevated risk for secondary cancers...
  14. ncbi Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients
    Ying J Hitchcock
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84112, USA
    Int J Radiat Oncol Biol Phys 73:779-88. 2009
    ....
  15. ncbi Identification of gene expression profiles that segregate patients with childhood leukemia
    Philip J Moos
    Center for Children at the Huntsman Cancer Institute and Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
    Clin Cancer Res 8:3118-30. 2002
    ....
  16. ncbi Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data
    Lisa Hazard
    Huntsman Cancer Institute at the University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
    Cancer 110:2191-201. 2007
    ..For the current study, the authors evaluated the effect of preoperative and postoperative radiation therapy on survival in patients with pancreatic adenocarcinoma...
  17. ncbi Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Hospital and University of Utah Medical Center, Salt Lake City, Utah 99202, USA
    Cancer 110:2092-100. 2007
    ....
  18. ncbi Gene expression profiling. Methods and clinical applications in oncology
    E A Raetz
    Department of Pediatrics, Division of Hematology-Oncology, Huntsman Cancer Institute, University of Utah School of Medicine, Primary Children's Medical Center, Salt Lake City, Utah, USA
    Hematol Oncol Clin North Am 15:911-30, ix. 2001
    ..This article discusses different genomic technologies, statistical methods for data analysis, and clinical applications of microarrays. Emphasis is devoted to integration of microarrays into the field of pediatric oncology...
  19. ncbi Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Hospital and University of Utah Medical Center, Salt Lake City 84112-5560, USA
    JAMA 295:389-97. 2006
    ..Future work is needed to continue to delineate clinical and biological factors, which can guide treatment decisions and account for disparities in outcome between varied subsets of patients...
  20. ncbi Quantifying the role of PSA screening in the US prostate cancer mortality decline
    Ruth Etzioni
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Causes Control 19:175-81. 2008
    ..To quantify the plausible contribution of prostate-specific antigen (PSA) screening to the nearly 30% decline in the US prostate cancer mortality rate observed during the 1990s...

Research Grants1

  1. Understanding racial differences in the natural history of prostate cancer
    Aniko Szabo; Fiscal Year: 2007
    ..abstract_text> ..